Our production sites record measurable impacts under OPS 2.0

In biopharmaceutical manufacturing, progress is often built on a series of small but meaningful refinements. By challenging established routines and introducing smarter, more sustainable ways of working, teams across Octapharma are strengthening the foundations for further innovation.

In 2025, OPS 2.0 - the enhanced Octapharma Production System and a core pillar of our long-term strategy - advanced from concept to implementation, and is now embedded across the production network - enabling teams to pursue operational excellence with greater consistency and impact.

OPS 2.0: From framework to culture

OPS 2.0 represents the evolution of the Octapharma Production System. While OPS 1.0 already focused on increasing throughput by working more efficiently with the resources we have, OPS 2.0 extends this approach. The shift now goes beyond optimising output and places stronger emphasis on cost efficiency across all areas. Teams are encouraged to challenge routines, simplify processes, and use resources with greater precision.

This shift reflects the central purpose of OPS 2.0: building long-term competitiveness through continuous improvement.

“Efficiency isn’t just about cost control. It’s about creating capacity for innovation,” says Diana Wedenlid, Group Senior Director for Operational Excellence. “In 2025, this focus led to a meaningful step forward. Thanks to the initiatives introduced under OPS 2.0, our overall cost development remained stable, showing how disciplined improvement and the growing ownership of efficiency across our sites translate directly into greater capacity to reach patients.”

This evolution is also reflected in the way teams are embracing OPS 2.0. Diana notes that what began as a framework is now becoming a shared culture across sites, with ownership, collaboration and everyday efficiency shaping how teams work.

Turning ideas into positive impact

The benefits of this transformation are now increasingly visible. Teams are simplifying processes, reducing waste, and focusing more time on value-adding activities. Individually, many of these improvements may appear modest - but together, they have created measurable gains across the network.

Enhancements in planning, process optimisation and automation are strengthening reliability and throughput - supporting our ability to deliver medicines more efficiently. OPS 2.0 demonstrates clearly that sustained, practical innovation is essential not only for operational performance, but also in order to meet the needs of patients worldwide.

“Efficiency - in this sense - becomes both an operational and an ethical commitment,” adds Delphine Vivier, Group Lead Expert Operational Excellence. “It’s how Octapharma ensures that each litre of plasma, each batch of product, and each hour of work produces maximum impact.”

What is OPS 2.0?

“An OPS 2.0 initiative is started based on an improvement idea originating from within a site or corporate function. It delivers a clearly identified and measurable benefit in addition to the other top-down strategic programmes for capacity, quality, safety or sustainability."

Olivier Clairotte
Chief Production Officer